Citizens Maintains Market Outperform on Pharvaris, Raises Price Target to $75

Benzinga · 2d ago
Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:PHVS) with a Market Outperform and raises the price target from $74 to $75.